0 items USD 0.00Search
Your search for "gbi research pancreatic cancer therapeutics major developed markets 2021 strong late stage pipeline" gave back 83620 results.
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
Catalog:
CBR Pharma Insights
September 2015
Price: USD 2,995.00
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities The field of oncolytic viruses...
Catalog:
La Merie Publishing
January 2017
Price: USD 2,400.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Competitor Analysis: KRAS Inhibitors This Competitive Intelligence report about KRAS Inhibitors evaluates the landscape of investigational small...
Catalog:
La Merie Publishing
October 2019
Price: USD 280.00
Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Over the past 50 years, the nuclear medicine field has displayed a strong link between investments in chemistry and the development of radionuclide...
Catalog:
IQ4I
September 2020
Price: USD 4,950.00
Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, "Innovation Tracking...
CBR Pharma Insights
June 2016
Price: USD 2,995.00
Men’s health refers to conditions that specifically affect males, or those that are not gender-specific but have different outcomes in men. Although...
Catalog:
CBR Pharma Insights
March 2015
Price: USD 2,995.00
Report Package: Bispecific Antibodies This report package includes the full report T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a...
Catalog:
La Merie Publishing
July 2019
Price: USD 2,840.00
Type 2 Diabetes (T2D) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of T2D. The global Type 2...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
